The largest database of trusted experimental protocols

Synthetic tipped applicator

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Synthetic-tipped Applicator is a laboratory tool designed for the controlled transfer of liquids or other materials. It features a synthetic tip that can be used to apply, spread, or manipulate small quantities of substances during scientific experimentation or sample preparation.

Automatically generated - may contain errors

3 protocols using synthetic tipped applicator

1

Isolation and Quantification of Blood and Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected in BD Vacutainer® CPT Cell Preparation Tubes and PBMCs were isolated following the manufacturer’s protocol. Plasma was immediately frozen at − 70 °C in 500 μl aliquots for TFV, medroxyprogesterone acetate (MPA), and progesterone analysis. PBMCs were treated with BioLegend red blood cell (RBC) lysis buffer to minimize interference of RBCs in TFV-DP quantification. Cells counts and viability were determined using trypan blue exclusion on the Countess I (Invitrogen).
Rectal and vaginal tissues biopsies were collected using medical forceps with three pinches collected at each site. Extraneous liquid was carefully removed, and tissue was weighed on an analytical balance; with a median of 15.9 mg of rectal tissue and 20.3 mg of vaginal tissue collected per sample. Due to the small amount of tissue collected from four animals in the DMPA− group in Phase 1, tissues were combined into two pools (two animals each) to ensure sufficient yield of TFV-DP and dATP. This resulted in only two data points for analysis (denoted by triangles in Fig. 3A and B). Biopsies were not combined in any of the subsequent experiments from Phase 1 or 2.
Swabs (Fisherbrand Synthetic-tipped Applicator) were inserted in the vagina and rectum for 5 min to ensure uptake of mucosal secretions. The volume of fluid for each sample was determined by weighing the swabs pre- and post-collection.
+ Open protocol
+ Expand
2

Comprehensive Biospecimen Collection for Mucosal Immunity Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected in BD Vacutainer® CPT™ Cell Preparation Tubes and PBMCs were isolated following the manufacturer’s protocol. Plasma aliquots of 500 µL were immediately frozen at −70 °C for ISL, ENG and progesterone analyses. PBMCs were treated with BioLegend red blood cell (RBC) lysis buffer (BioLegend, San Diego, CA, USA) and then counted using trypan blue exclusion on the Countess II FL (Invitrogen, Carlsbad, CA, USA). Vaginal and rectal mucosal fluids and tissue biopsies were collected once every two weeks. Swabs (Fisherbrand™ Synthetic-tipped Applicator, Waltham, MA, USA) were inserted in the vagina and rectum for five minutes to ensure uptake of mucosal secretions. The volume of fluid for each sample was determined by weighing the swabs pre- and post-collection. Tissue samples were taken with medical forceps (Boston Scientific Radial Jaw 4 Forceps, 2.2 mm jaw, 160 length), and three pinches were attempted at each site. Extraneous liquid was carefully removed, and tissue was weighed on an analytical balance.
+ Open protocol
+ Expand
3

Isolation and Quantification of Blood and Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected in BD Vacutainer® CPT Cell Preparation Tubes and PBMCs were isolated following the manufacturer’s protocol. Plasma was immediately frozen at − 70 °C in 500 μl aliquots for TFV, medroxyprogesterone acetate (MPA), and progesterone analysis. PBMCs were treated with BioLegend red blood cell (RBC) lysis buffer to minimize interference of RBCs in TFV-DP quantification. Cells counts and viability were determined using trypan blue exclusion on the Countess I (Invitrogen).
Rectal and vaginal tissues biopsies were collected using medical forceps with three pinches collected at each site. Extraneous liquid was carefully removed, and tissue was weighed on an analytical balance; with a median of 15.9 mg of rectal tissue and 20.3 mg of vaginal tissue collected per sample. Due to the small amount of tissue collected from four animals in the DMPA− group in Phase 1, tissues were combined into two pools (two animals each) to ensure sufficient yield of TFV-DP and dATP. This resulted in only two data points for analysis (denoted by triangles in Fig. 3A and B). Biopsies were not combined in any of the subsequent experiments from Phase 1 or 2.
Swabs (Fisherbrand Synthetic-tipped Applicator) were inserted in the vagina and rectum for 5 min to ensure uptake of mucosal secretions. The volume of fluid for each sample was determined by weighing the swabs pre- and post-collection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!